Abstract:Ketamine is primarily known as an effective NMDAR (N-methyl-D-aspartic acid receptor) blocker.As one of the intravenous anesthetics,ketamine has been widely used in clinical practice for more than 50 years,exhibiting several different outcomes besides the original anesthetic effects.Recent studies provide insights into the mechanisms of the following neuropharmacological effects of ketamine:(i) Anesthesia.The anesthetic effects of ketamine are mainly due to its ability to decrease the inter-cortical communications to generate dissociative anesthesia.Besides the well-known NMDAR,another target for ketamine to show anesthetic effects has been reported to be hyperpolarization-activated cyclic nucleotide-gated channels (HCN channels).(ii) Analgesia.Ketamine not only exhibits blockade on NMDAR in the central nervous system,but also reverses opioid tolerance when combined with morphine at a low dose.The affinity with sodium and potassium channels makes ketamine possible for analgesia at high doses.However,the clinical analgesic effect is currently controversial,and the algetic cases after the discontinuation of ketamine are probably caused by its metabolic product norketamine.(iii) Anti-depression.Ketamine is recently regarded as a rapid antidepressant drug for its contribution to neurogenesis through several molecular processes,such as the glutamate burst by activating presynaptic NMDAR and AMPAR (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor),the synaptic protein synthesis and transportation by activating mTOR (mechanistic target of rapamycin),and the synaptic maturation by releasing BDNF (brain derived neurotrophic factor).At the circuit level,ketamine widely reconstructs circuits by dual regulation on NMDAR and AMPAR,and causes loss of phenotype of the PV GABAergic neurons (parvalbumin-positive interneurons).(iv) Side effects.Ketamine is strictly constrained for its psychiatric side effects resulted from the potent disruption on neural network stability,which shares similar neuro-circuit etiology with schizophrenia.Also,the potential ketamine-induced neuroapoptosis might generate risks for anesthesia during pregnancy and childhood,which is under deep investigation.Due to the potential risks of ketamine,more attention should be paid to the development of novel anesthetics keeping the anesthetic,analgesic and antidepressant effects of ketamine,however,without the potential psychiatric side effects.Thus,exceeding novel knowledge,makes ketamine a representative example for the complexity of anesthetics due to its global targets and dose-dependent properties,which provides a breakthrough point both for the mechanism researches for the working models of general anesthetics and for exploring the state of consciousness of human beings.

[Suppression Effect of Ketamine on Transient Outward Potassium Currents in Rathippocampal Neurons].

Suppression of Delayed Rectifier Potassium Currents in Rat Hippocampal Neurons by Ketamine

Effect of Ketamine on High-voltage-activated Calcium Currents in Rat Hippocampal Neurons

Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex.

Effect of Etomidate on Voltage-Dependent Potassium Currents in Rat Isolated Hippocampal Pyramidal Neurons

Electrophysiological Effects Of Ketamine On Human Atrial Myocytes At Therapeutically Relevant Concentrations

Changes in the gene and protein expression of KATP channel subunits in the hippocampus of rats subjected to picrotoxin-induced kindling

Ketamine blockage of both tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels of rat dorsal root ganglion neurons

Effects of Pethidine on Cardiac Electrophysiological Properties

Alterations in Regional Homogeneity of Resting-State Brain Activity in Ketamine Addicts

Ketamine, Propofol, and the EEG: A Neural Field Analysis of HCN1-Mediated Interactions

[Suppressive Effect of Propofol on Low-Voltage-activated Calcium Currents in Rat Hippocampal Neurons].

Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state

Allosteric inhibition of NMDA receptors by low dose ketamine

s-ketamine enhances thalamocortical and corticocortical synaptic transmission in acute murine brain slices via increased AMPA-receptor-mediated pathways

Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors

Effect of propofol on high- voltage-activated calcium currents in rat hippocampal neurons

Effect of Ketamine on Brain Electrical Activity in Cat Motor Cortex

Region-specific effects of repeated ketamine administration on the presynaptic GABAergic neurochemistry in rat brain

Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines

Research progress in the mechanisms of the clinical effects of ketamine